• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

维生素D受体基因多态性与癌症风险的综述及荟萃分析

Review and meta-analysis on vitamin D receptor polymorphisms and cancer risk.

作者信息

Raimondi Sara, Johansson Harriet, Maisonneuve Patrick, Gandini Sara

机构信息

Division of Epidemiology and Biostatistics, European Institute of Oncology, Via Ripamonti 435, Milan, Italy.

出版信息

Carcinogenesis. 2009 Jul;30(7):1170-80. doi: 10.1093/carcin/bgp103. Epub 2009 Apr 29.

DOI:10.1093/carcin/bgp103
PMID:19403841
Abstract

It was suggested that vitamin D levels influence cancer development. The vitamin D receptor (VDR) is a crucial mediator for the cellular effects of vitamin D. Results from previous studies on the association of VDR polymorphisms with different cancer types are somewhat contradictory, and the role of VDR in the etiology of cancer is still equivocal. We therefore performed a meta-analysis on the association between the two most studied VDR polymorphisms (FokI and BsmI) and any cancer site. Up to January 2009, we identified 67 independent studies. We used random-effects models to provide summary odds ratio (SOR) for VDR polymorphisms and cancer. We tested homogeneity of effects across studies and publication bias and explored between-study heterogeneity. When comparing FokI ff with FF carriers, we found a significant increase in skin cancer [SOR; 95% confidence intervals (CIs): 1.30; 1.04-1.61] and breast cancer (SOR; 95%CI: 1.14; 1.03-1.27) risk. For the same genotype comparison, we found a significantly higher risk of cancer when we pooled estimates from cancer sites possibly associated with vitamin D levels (prostate, breast, skin, ovary, non-Hodgkin lymphoma and colorectal). A significant reduction in prostate cancer risk was observed for carriers of BsmI Bb compared with bb genotype (SOR; 95%CI: 0.83; 0.69-0.99). In Caucasian populations, both Bb and BB carriers had a significant reduced risk of cancer at any site. In conclusion, this meta-analysis showed that VDR FokI and BsmI polymorphisms might modulate the risk of cancer of breast, skin and prostate and possibly affect cancer risk at any site in Caucasians.

摘要

有人提出维生素D水平会影响癌症的发展。维生素D受体(VDR)是维生素D细胞效应的关键介质。先前关于VDR基因多态性与不同癌症类型关联的研究结果有些相互矛盾,VDR在癌症病因学中的作用仍不明确。因此,我们对研究最多的两种VDR基因多态性(FokI和BsmI)与任何癌症部位之间的关联进行了荟萃分析。截至2009年1月,我们确定了67项独立研究。我们使用随机效应模型来提供VDR基因多态性与癌症的汇总比值比(SOR)。我们检验了各研究间效应的同质性和发表偏倚,并探讨了研究间的异质性。当比较FokI ff与FF携带者时,我们发现皮肤癌[SOR;95%置信区间(CI):1.30;1.04 - 1.61]和乳腺癌(SOR;95%CI:1.14;1.03 - 1.27)风险显著增加。对于相同的基因型比较,当我们汇总可能与维生素D水平相关的癌症部位(前列腺、乳腺、皮肤、卵巢、非霍奇金淋巴瘤和结肠直肠癌)的估计值时,发现患癌风险显著更高。与bb基因型相比,BsmI Bb携带者的前列腺癌风险显著降低(SOR;95%CI:0.83;0.69 - 0.99)。在白种人群中,Bb和BB携带者在任何部位患癌的风险均显著降低。总之,这项荟萃分析表明,VDR FokI和BsmI基因多态性可能会调节乳腺癌、皮肤癌和前列腺癌的风险,并可能影响白种人在任何部位患癌的风险。

相似文献

1
Review and meta-analysis on vitamin D receptor polymorphisms and cancer risk.维生素D受体基因多态性与癌症风险的综述及荟萃分析
Carcinogenesis. 2009 Jul;30(7):1170-80. doi: 10.1093/carcin/bgp103. Epub 2009 Apr 29.
2
Vitamin D receptor polymorphisms and breast cancer risk: results from the National Cancer Institute Breast and Prostate Cancer Cohort Consortium.维生素D受体基因多态性与乳腺癌风险:来自美国国立癌症研究所乳腺癌和前列腺癌队列联盟的结果。
Cancer Epidemiol Biomarkers Prev. 2009 Jan;18(1):297-305. doi: 10.1158/1055-9965.EPI-08-0539.
3
Vitamin D receptor gene polymorphisms and breast cancer risk.维生素D受体基因多态性与乳腺癌风险
Clin Cancer Res. 2004 Aug 15;10(16):5472-81. doi: 10.1158/1078-0432.CCR-04-0206.
4
Vitamin D receptor polymorphisms, circulating vitamin D metabolites, and risk of prostate cancer in United States physicians.美国医生中维生素D受体基因多态性、循环维生素D代谢产物与前列腺癌风险
Cancer Epidemiol Biomarkers Prev. 1998 May;7(5):385-90.
5
Vitamin D and skin cancer: a meta-analysis.维生素D与皮肤癌:一项荟萃分析。
Eur J Cancer. 2009 Mar;45(4):634-41. doi: 10.1016/j.ejca.2008.10.003. Epub 2008 Nov 12.
6
Associations between polymorphisms in the vitamin D receptor and breast cancer risk.维生素D受体基因多态性与乳腺癌风险之间的关联。
Cancer Epidemiol Biomarkers Prev. 2005 Oct;14(10):2335-9. doi: 10.1158/1055-9965.EPI-05-0283.
7
BsmI polymorphism of vitamin D receptor gene and cancer risk: a comprehensive meta-analysis.维生素D受体基因的BsmI多态性与癌症风险:一项全面的荟萃分析。
Mutat Res. 2014 Nov;769:17-34. doi: 10.1016/j.mrfmmm.2014.06.001. Epub 2014 Jun 23.
8
Vitamin D receptor gene polymorphisms are associated with increased risk and progression of renal cell carcinoma in a Japanese population.维生素D受体基因多态性与日本人群肾细胞癌风险增加及病情进展相关。
Int J Urol. 2007 Jun;14(6):483-7. doi: 10.1111/j.1442-2042.2007.01771.x.
9
Vitamin D receptor gene polymorphisms and epithelial ovarian cancer risk.维生素D受体基因多态性与上皮性卵巢癌风险
Cancer Epidemiol Biomarkers Prev. 2007 Dec;16(12):2566-71. doi: 10.1158/1055-9965.EPI-07-0753.
10
Vitamin D receptor genotypes/haplotypes and prostate cancer risk.维生素D受体基因型/单倍型与前列腺癌风险
Cancer Epidemiol Biomarkers Prev. 2006 Dec;15(12):2549-52. doi: 10.1158/1055-9965.EPI-06-0409.

引用本文的文献

1
Vitamin D and Clinical Outcomes in Head and Neck Cancer: A Systematic Review.维生素D与头颈癌的临床结局:一项系统评价
Nutrients. 2025 Mar 21;17(7):1100. doi: 10.3390/nu17071100.
2
Are Pediatric Cancer Patients a Risk Group for Vitamin D Deficiency? A Systematic Review.儿科癌症患者是维生素D缺乏的风险群体吗?一项系统评价。
Cancers (Basel). 2024 Dec 17;16(24):4201. doi: 10.3390/cancers16244201.
3
Vitamin D in Cancer Prevention and Treatment: A Review of Epidemiological, Preclinical, and Cellular Studies.维生素D在癌症预防与治疗中的作用:流行病学、临床前及细胞研究综述
Cancers (Basel). 2024 Sep 20;16(18):3211. doi: 10.3390/cancers16183211.
4
Vitamin D deficiency and the vitamin D receptor (VDR) gene polymorphism rs2228570 (FokI) are associated with an increased susceptibility to hypertension among the Bangladeshi population.维生素 D 缺乏和维生素 D 受体(VDR)基因多态性 rs2228570(FokI)与孟加拉国人群中高血压易感性增加有关。
PLoS One. 2024 Mar 14;19(3):e0297138. doi: 10.1371/journal.pone.0297138. eCollection 2024.
5
The Relationship between Gene Polymorphisms and with Breast Cancer Risk.基因多态性与乳腺癌风险之间的关系。 (注:原英文表述有误,多了一个“with”,正确表述应该是The Relationship between Gene Polymorphisms and Breast Cancer Risk )
Glob Med Genet. 2024 Mar 4;11(1):69-75. doi: 10.1055/s-0044-1779040. eCollection 2024 Jan.
6
Immunohistochemical Expression of Vitamin D Receptor (VDR) in Urinary Bladder Squamous Cell Carcinoma.维生素 D 受体(VDR)在膀胱鳞状细胞癌中的免疫组化表达。
Turk Patoloji Derg. 2024;1(1):109-116. doi: 10.5146/tjpath.2023.12863.
7
Impact of vitamin D receptor gene polymorphisms (TaqI and BsmI) on the incidence and severity of coronary artery disease: a report from southern Iran.维生素 D 受体基因多态性(TaqI 和 BsmI)对冠状动脉疾病发生率和严重程度的影响:来自伊朗南部的报告。
BMC Cardiovasc Disord. 2023 Mar 7;23(1):113. doi: 10.1186/s12872-023-03155-5.
8
Vitamin D intake and gastric cancer in Viet Nam: a case-control study.维生素 D 摄入与越南胃癌的关系:病例对照研究。
BMC Cancer. 2022 Aug 1;22(1):838. doi: 10.1186/s12885-022-09933-2.
9
Sun Exposure Makes no Discrimination based on Vitamin D Status and VDR-Foki Polymorphisms for Non-Melanoma Skin Cancers Risk in Iranian Subjects: A Case-Control Study.阳光暴露对非黑素瘤皮肤癌风险在伊朗人群中没有因维生素 D 状态和 VDR-Foki 多态性而产生歧视:一项病例对照研究。
Asian Pac J Cancer Prev. 2022 Jun 1;23(6):1927-1933. doi: 10.31557/APJCP.2022.23.6.1927.
10
Vitamin D and Hypoxia: Points of Interplay in Cancer.维生素D与低氧:癌症中的相互作用点
Cancers (Basel). 2022 Mar 31;14(7):1791. doi: 10.3390/cancers14071791.